Citadel Advisors »

Kyverna Therapeutics shares owned by Citadel Advisors

Quarter-by-quarter ownership of Kyverna Therapeutics (KYTX) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Kyverna Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Kyverna Therapeutics held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kyverna Therapeutics by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $748k 153k 4.89
2024-06-30 $1.9M 248k 7.50
2024-03-31 $13M 531k 24.84

More positions owned by Citadel Advisors

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
NVIDIA Corporation Call Option (NVDA)
Tesla Motors Call Option (TSLA)
Apple Call Option (AAPL)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Meta Platforms Cl A Call Option (META)
Microsoft Corporation Call Option (MSFT)
Amazon Call Option (AMZN)
Advanced Micro Devices Call Option (AMD)
Broadcom Call Option (AVGO)
Netflix Call Option (NFLX)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Booking Holdings Call Option (BKNG)
Spdr Gold Tr Gold Shs Call Option (GLD)

View all positions for Citadel Advisors

Top funds holding Kyverna Therapeutics

Vida Ventures Advisors
Bain Capital Life Sciences Investors
Northpond Ventures
Jpmorgan Chase & Co
Novo A/S
BlackRock
BlackRock
Vanguard Group
Franklin Resources
Deerfield Management Company
Insight Holdings
T. Rowe Price Associates
Mbb Public Markets I
EcoR1 Capital
Geode Capital Management

View all funds holding Kyverna Therapeutics